Phase II Trial - Breast Cancer Chemoprevention by Lovastatin

This study has been terminated.
(Slow accrual)
Sponsor:
Information provided by (Responsible Party):
James Ford, Stanford University
ClinicalTrials.gov Identifier:
NCT00285857
First received: January 31, 2006
Last updated: June 5, 2014
Last verified: June 2014